Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRestore Regulatory News (RST)

Share Price Information for Restore (RST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    -1.00 (-0.39%)
Bid:
253.00
Ask:
255.00
Spread: 2.00 (0.791%)
Market Cap: £339.42m
RST Live PriceLast checked at - London Stock Exchange

Intraday Restore Share Chart

Non-Executive Directorate Change

19 Apr 2022 07:00

RNS Number : 4842I
Restore PLC
19 April 2022
 

19 April 2022

 

Restore plc

("Restore" or the "Group" or "Company")

 

Non-Executive Directorate change

 

 

Restore (AIM: RST), the UK's leading provider of digital and information management and secure lifecycle services, is pleased to announce the appointment of Lisa Fretwell as an independent Non-Executive Director.

 

Lisa will be appointed to the Board as a Non-Executive Director on 20th April 2022 and will also become Chair of the Group's Risk Committee, a role currently undertaken by Sharon Baylay-Bell, from that date. Lisa will also join the Audit and Nomination Committees.

 

Lisa was most recently Managing Director for Experian's UK Data Business, prior to which she held senior roles in transformation and consulting for various technology organisations including Cisco and Cap Gemini. Lisa is also a Non-Executive Director of Santander UK.

 

In accordance with Company policy, Lisa will resign and offer herself for re-election at Restore's Annual General Meeting scheduled to be held on 20th May 2022.

 

SHARON BAYLAY-BELL, CHAIR, COMMENTED:

 

"I am delighted to welcome Lisa to the Board of Restore at a key moment in our evolution. Lisa has a strong background of supporting fast growth technology businesses and with the Group's increasing digital and technology focus, we look forward to benefitting from her experiences.

 

Lisa has also led organisations that operate in complex commercial and risk environments and I am sure that her experiences in these areas will bring additional depth and insight to the Group's Risk Committee."

 

 

For further information:

Restore plc

www.restoreplc.com

Charles Bligh, CEONeil Ritchie, CFO

+44 (0) 207 409 2420

Investec (Nominated Adviser and Joint Broker)

www.investec.com

Carlton Nelson

James Rudd

Harry Hargreaves

William Brinkley

+44 (0) 207 597 5970

Canaccord Genuity (Joint Corporate Broker)

www.canaccordgenuity.com

Max Hartley

Chris Robinson

Simon Bridges

+44 (0) 207 523 8000

Citi (Joint Corporate Broker)

www.citigroup.com

Stuart Field

Luke Spells

Charles Mortimer

+44 (0 )207 986 4074

Buchanan Communications (PR enquiries)

www.buchanan.uk.com

Charles Ryland

Stephanie Whitmore

Jack Devoy

+44 (0) 207 466 5000

 

The following information in relation to the appointment of Lisa Fretwell (aged 51) are disclosed in accordance with Rule 17 and Schedule Two, paragraph (g) of the AIM Rules.

Current Directorships

Directorships held in the last five years

Santander UK PLC

Castlight Ltd

Santander UK Group Holdings PLC

Runpath Regulated Services Limited

 

There are no other disclosures required in accordance with Rule 17 and Schedule Two, paragraph (g) of the AIM Rules

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFUFMLEESELL
Date   Source Headline
1st Jun 202610:55 amRNSTransaction in Own Shares
26th May 20261:49 pmRNSTransaction in Own Shares
22nd May 20267:00 amRNSDirector/PDMR Shareholding
18th May 202610:27 amRNSTransaction in Own Shares
13th May 202612:45 pmRNSResult of Annual General Meeting
12th May 20267:00 amRNSTrading update
11th May 202611:10 amRNSTransaction in Own Shares
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20269:31 amRNSHolding(s) in Company
5th May 20261:05 pmRNSTransaction in Own Shares
27th Apr 202610:45 amRNSTransaction in Own Shares
23rd Apr 20262:00 pmRNSHolding(s) in Company
20th Apr 20269:58 amRNSTransaction in Own Shares
13th Apr 20269:43 amRNSTransaction in Own Shares
9th Apr 20261:58 pmRNSBoard Change
9th Apr 20267:00 amRNSDirector/PDMR Shareholding
8th Apr 202611:46 amRNSHolding(s) in Company
7th Apr 202610:02 amRNSTransaction in Own Shares
30th Mar 202611:12 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
16th Mar 20267:00 amRNSCommencement of £20m Share Buyback Programme
12th Mar 20267:00 amRNSFull Year 2025 Results
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
11th Mar 20269:00 amRNS-RInvestor Presentation with Equity Development
9th Mar 20269:23 amRNSHolding(s) in Company
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
19th Dec 202512:55 pmRNSDirector/PDMR Shareholding
10th Dec 202511:33 amRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSHolding(s) in Company
9th Dec 20257:01 amRNSDisposal of Restore Harrow Green
9th Dec 20257:00 amRNSTrading update
23rd Oct 20254:00 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSAnalyst and investor site visit
29th Jul 20257:00 amRNSHalf year 2025 results
14th Jul 202511:39 amRNS-RNotice of Presentation with Equity Development
7th Jul 202511:10 amRNSHolding(s) in Company
16th Jun 20252:28 pmRNSHoldings in Company
14th May 20251:12 pmRNSGrant of SAYE Options and PDMR Dealings
13th May 20253:10 pmRNSResult of AGM
13th May 20257:00 amRNSTrading update
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
28th Mar 20252:02 pmRNSHolding(s) in Company
20th Mar 20253:59 pmRNSHolding(s) in Company
17th Mar 20253:56 pmRNSHolding(s) in Company
17th Mar 20251:48 pmRNSDirector/PDMR Shareholding
14th Mar 20258:37 amRNSDirector/PDMR Shareholding
13th Mar 202512:24 pmRNSDirector/PDMR Shareholding
13th Mar 20257:00 amRNSFull year 2024 results
13th Mar 20257:00 amRNSAcquisition of Synertec (Holdings) Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.